Login / Signup

Efficacy and safety of Tolvaptan in cirrhotic patients: a systematic review and meta-analysis of randomized controlled trials.

Lu ChaiZhe LiTing WangRan WangKanokwan PinyopornpanishGang ChengXing Shun Qi
Published in: Expert review of gastroenterology & hepatology (2023)
Short-term use of tolvaptan may be considered in cirrhotic patients with ascites who have inadequate response to conventional diuretics and those with hyponatremia.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • acute heart failure
  • chronic kidney disease
  • systematic review
  • prognostic factors
  • heart failure